MedPath

Cost-effectiveness of two treatment strategies of an anterior cruciate ligament rupture. A randomized clinical study.

Completed
Conditions
ACL, anterior cruciate ligament , rupture, treatment options, VKB, Voorste kruisband ruptuur, behandelmogelijkheden,
Registration Number
NL-OMON26654
Lead Sponsor
Prof. dr. J.A.N. Verhaar (Chair Department of Orthopaedics at Erasmus MC )
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
166
Inclusion Criteria

1. MRI proven ACL tear and/or on physical examination high suspection of ACL tear;

2. Age 18-65;

Exclusion Criteria

1. Associated PCL injury or injury to the lateral/posterolateral ligament complex with significantly increased laxity;

2. Pregnancy;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical effect in change in International Knee Documentation Committee” (IKDC) questionnaire over a period of 24 months between the early surgical group and the more conservative treatment group.
Secondary Outcome Measures
NameTimeMethod
Difference in scores of IKDC (objective form), KOOS, Lysholm, Tegner, pain severity (VAS), objective instability (KT-1000, Lachman and pivot shift test), satisfaction with treatment, and quality of life (EQ5D). Besides, differences in medical consumption, adverse events (menisci lesions, complications, and re-interventions), absence from work or decreased productivity at paid and unpaid work, and patient costs (PRODISQ, productivity and Disease Questionnaire), to be able to do cost-effectiveness analysis will be assessed.
© Copyright 2025. All Rights Reserved by MedPath